THERE IS NO CORRELATION BETWEEN STAGES OF NAFLD ASSESSED BY LIVER BIOPSY AND THE DIAGNOSTIC CRITERIA FOR SARCOPENIA IN ACTIVE POPULATIONS: A CROSS-SECTIONAL STUDY

Autores

  • Luis Fernando Ferreira Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
  • Kally Janaina Berleze Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
  • André Ferreira D´Ávila Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
  • Cristiane Valle Tovo Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
  • Luis Henrique Telles da Rosa Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)

DOI:

https://doi.org/10.25110/arqsaude.v27i10.2023-032

Palavras-chave:

Non-Alcoholic Fatty Liver Disease, Sarcopenia, Exercise

Resumo

Objective: To demonstrate the correlations of the diagnostic criteria for sarcopenia and the levels of Non-alcoholic Fat Liver Disease (NAFLD) assessed by liver biopsy in a physically active population. Methods: Cross-sectional study. Individuals aged >18 years, with NAFLD confirmed by liver biopsy, physically active. Sarcopenia assessment followed EWGSOP2: muscle strength by handgrip, Skeletal Muscle Mass by Bioimpedance, and physical performance by usual gait speed. Statistical Analysis: To test differences between groups in continuous variables, Student's T or Mann-Whitney U Test for independent samples. Pearson and Spearman tests were used for correlations. A 5% significance was considered (p<0.05). Results: 52 patients with NAFLD included, consisting of 35 women and 15 men. There was no difference in age or anthropometric variables.  Were found difference statically significant in platelets (higher in women), basal insulin, HOMA-IR and Quick (higher in men). In sarcopenia, the handgrip strength showed difference in favors of men. There was no statistically significant correlation between the sarcopenia and NAFLD levels. Discussion: sarcopenia has been reported as an independent risk factor for NAFLD and its progressions. The physical exercise is one of the most recommended and more effective treatment for both conditions, so is expected that a non-sedentary individual can reduce both indicators. However, there is no consensus about the best method. Also, the both conditions share heterogeneity in diagnosis, prognosis, reason for develop and risk factors across the literature. Conclusion: For populations where most individuals are physically active, it is not possible to find correlation between sarcopenia diagnostic criteria and the stages of NAFLD.

Referências

Tovo, C.V., et al., Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. World J Hepatol, 2017. 9(6): p. 326-332.DOI: 10.4254/wjh.v9.i6.326

Silva, A.D.D., et al., Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis. Rev Assoc Med Bras (1992), 2021. 67(11): p. 1665-1669.DOI: 10.1590/1806-9282.20210718

Zambon Azevedo, V., et al., Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr, 2021. 8: p. 774030.DOI: 10.3389/fnut.2021.774030

Fernández, T., et al., Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLoS One, 2022. 17(2): p. e0263931.DOI: 10.1371/journal.pone.0263931

Rosenberg, I.H., Sarcopenia: origins and clinical relevance. Clin Geriatr Med, 2011. 27(3): p. 337-9.DOI: 10.1016/j.cger.2011.03.003

Feinstein, A., Icd-10. Int J Soc Psychiatry, 1993. 39(3): p. 157-8.DOI: 10.1177/002076409303900301

Ebner, N. and S. von Haehling, [Cachexia and sarcopenia in chronic heart failure : Change in muscle strength and muscle structure]. Internist (Berl), 2018. 59(5): p. 439-444.DOI: 10.1007/s00108-018-0408-3

Gungor, O., et al., Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle, 2021. 12(6): p. 1380-1392.DOI: 10.1002/jcsm.12839

Tyrovolas, S., et al., Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle, 2016. 7(3): p. 312-21.DOI: 10.1002/jcsm.12076

Petermann-Rocha, F., et al., Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle, 2022. 13(1): p. 86-99.DOI: 10.1002/jcsm.12783

Cadore, E.L., et al., Effects of Different Exercise Interventions on Risk of Falls, Gait Ability, and Balance in Physically Frail Older Adults: A Systematic Review. Rejuvenation Res, 2013. 16(2): p. 105-14.DOI: 10.1089/rej.2012.1397

Golabi, P., et al., Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Rep, 2020. 2(6): p. 100171.DOI: 10.1016/j.jhepr.2020.100171

Gonzalez, A., et al., Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Transl Myol, 2021. 31(1).DOI: 10.4081/ejtm.2021.9630

Geloneze, B., et al., The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract, 2006. 72(2): p. 219-20.DOI: 10.1016/j.diabres.2005.10.017

Guerrero-Romero, F., et al., Fasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults. Arch Med Res, 2016. 47(5): p. 382-387.DOI: 10.1016/j.arcmed.2016.08.012

Katz, A., et al., Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab, 2000. 85(7): p. 2402-10.DOI: 10.1210/jcem.85.7.6661

Pai, R.K., et al., Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology, 2022. 76(4): p. 1150-1163.DOI: 10.1002/hep.32475

Bedossa, P., Current histological classification of NAFLD: strength and limitations. Hepatol Int, 2013. 7 Suppl 2: p. 765-70.DOI: 10.1007/s12072-013-9446-z

Cruz-Jentoft, A.J., et al., Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019. 48(1): p. 16-31

Fess, E.E., Grip Strength. In: Clinical assessment recommendations. Vol. 2. 1992, Chicago, IL.: American Society of Hand Therapists.

Kyle, U.G., et al., Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr, 2004. 23(6): p. 1430-53.DOI: 10.1016/j.clnu.2004.09.012

Janssen, I., et al., Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985), 2000. 89(2): p. 465-71.DOI: 10.1152/jappl.2000.89.2.465

Enright, P.L., The six-minute walk test. Respir Care, 2003. 48(8): p. 783-5

Matsudo, S., et al., Questionário Internacional de Atividade Física (IPAQ): Estudo de Validade e Reprodutibilidade no Brasil. Atividade Física e Saúde, 2001. 6(2): p. 14

Chun, H.S., et al., Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. J Cachexia Sarcopenia Muscle, 2021. 12(5): p. 1168-1178.DOI: 10.1002/jcsm.12754

Parameswaran, M., et al., Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus, 2021. 13(12): p. e20776.DOI: 10.7759/cureus.20776

Francque, S.M., et al., Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep, 2021. 3(5): p. 100322.DOI: 10.1016/j.jhepr.2021.100322

Ferreira, L.F., E.L. Scariot, and L.H.T. da Rosa, The effect of different exercise programs on sarcopenia criteria in older people: A systematic review of systematic reviews with meta-analysis. Archives of Gerontology and Geriatrics, 2023. 105: p. 104868.DOI: https://doi.org/10.1016/j.archger.2022.104868

Carneros, D., G. López-Lluch, and M. Bustos, Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 2020. 12(11).DOI: 10.3390/nu12113472

Calcaterra, V., et al., Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children (Basel), 2022. 9(8).DOI: 10.3390/children9081174

Babu, A.F., et al., Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. Nutrients, 2021. 13(9).DOI: 10.3390/nu13093135

Cruz-Jentoft, A.J., et al., Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) [with consumer summary]. Age and Ageing 2014 Nov;43(6):748-759, 2014

Escriche-Escuder, A., et al., Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: A systematic review and meta-analysis according to the EWGSOP criteria. Exp Gerontol, 2021. 151: p. 111420.DOI: 10.1016/j.exger.2021.111420

Ferreira, L.F., et al., Aerobic Training Does not Decrease the Prevalence of Sarcopenia in Older Women: Cross-Sectional Study. Ageing International, 2022.DOI: 10.1007/s12126-022-09485-7

Talar, K., et al., Benefits of Resistance Training in Early and Late Stages of Frailty and Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Clin Med, 2021. 10(8).DOI: 10.3390/jcm10081630

Chen, L.K., et al., Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc, 2020. 21(3): p. 300-307 e2.DOI: 10.1016/j.jamda.2019.12.012

Moon, J.H., B.K. Koo, and W. Kim, Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey. J Cachexia Sarcopenia Muscle, 2021. 12(4): p. 964-972.DOI: 10.1002/jcsm.12719

Pal, P., R. Palui, and S. Ray, Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. World J Hepatol, 2021. 13(11): p. 1584-1610.DOI: 10.4254/wjh.v13.i11.1584

Scheidt, L., et al., Nutrição Na Doença Hepática Gordurosa Não Alcoólica E Síndrome Metabólica: Uma Revisão Integrativa. . Arquivos De Ciências Da Saúde Da UNIPAR, 2018. 22(2).DOI: https://doi.org/10.25110/arqsaude.v22i2.2018.6365

Downloads

Publicado

27-10-2023

Como Citar

Ferreira, L. F., Berleze, K. J., D´Ávila, A. F., Tovo, C. V., & da Rosa, L. H. T. (2023). THERE IS NO CORRELATION BETWEEN STAGES OF NAFLD ASSESSED BY LIVER BIOPSY AND THE DIAGNOSTIC CRITERIA FOR SARCOPENIA IN ACTIVE POPULATIONS: A CROSS-SECTIONAL STUDY. Arquivos De Ciências Da Saúde Da UNIPAR, 27(10), 5961–5973. https://doi.org/10.25110/arqsaude.v27i10.2023-032

Edição

Seção

Artigos